99mtc(v) and 188re(v) dimercaptosuccinic acid (dmsa) quality control: an evaluation of different suppliers and labelling conditions.

• In: SIG Nuclear/Radiologic Pharmacy - Poster Session
• At: Salvadore (Brazil) (2006)
• Type: Poster
• Poster code: NR-P-006
• By: SAVIO, Eduardo (Facultad de Química, Montevideo, Uruguay)
• Co-author(s): Savio, Eduardo (Facultad de Química, MONTEVIDEO, Uruguay)
  Piuma, Lourdes (Facultad de Química, MONTEVIDEO, Uruguay)
  Paolino, Andrea (Facultad de Química, MONTEVIDEO, Uruguay)
  
• Abstract:

  99mTc(V)-DMSA has been widely adopted as the imaging agent of choice, mainly for medullary thyroid carcinoma. Rhenium analogue 188Re(V)-DMSA has also been evaluated for targeted radiotherapy of cancer. After labelling procedure following species were reported: different isomers as anti, syn-endo and syn-exo, but also other species could be..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login